Anika Therapeutics (ANIK) Short Interest Ratio & Short Volume $9.24 +0.15 (+1.65%) Closing price 04:00 PM EasternExtended Trading$9.23 -0.01 (-0.11%) As of 04:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Anika Therapeutics Short Interest DataAnika Therapeutics (ANIK) has a short interest of 360,100 shares, representing 2.62% of the float (the number of shares available for trading by the public). This marks a -10.91% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.8, indicating that it would take 2.8 days of the average trading volume of 91,398 shares to cover all short positions.Current Short Interest360,100 sharesPrevious Short Interest404,200 sharesChange Vs. Previous Month-10.91%Dollar Volume Sold Short$3.11 millionShort Interest Ratio2.8 Days to CoverLast Record DateSeptember 15, 2025Outstanding Shares14,420,000 sharesFloat Size13,720,000 sharesShort Percent of Float2.62%Today's Trading Volume55,955 sharesAverage Trading Volume91,398 sharesToday's Volume Vs. Average61% Short Selling Anika Therapeutics? Sign up to receive the latest short interest report for Anika Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartANIK Short Interest Over TimeANIK Days to Cover Over TimeANIK Percentage of Float Shorted Over Time Anika Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/2025360,100 shares $3.11 million -10.9%2.6%2.8 $8.65 8/31/2025404,200 shares $3.79 million +1.1%3.0%3.4 $9.38 8/15/2025400,000 shares $3.53 million +9.9%2.9%3.5 $8.83 7/31/2025363,900 shares $3.01 million +12.4%2.7%3.3 $8.26 7/15/2025323,700 shares $3.56 million -23.0%2.4%3.8 $11.00 6/30/2025420,300 shares $4.45 million -3.1%3.1%5.2 $10.58 6/15/2025433,700 shares $4.74 million +5.0%3.2%6.4 $10.93 5/31/2025413,000 shares $4.63 million +1.5%3.0%5.6 $11.20 5/15/2025407,000 shares $4.98 million +1.3%3.0%5.3 $12.24 4/30/2025401,700 shares $5.84 million +3.3%2.9%5.5 $14.53 Get the Latest News and Ratings for ANIK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Anika Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/15/2025388,800 shares $5.33 million -0.4%2.9%5.4 $13.72 3/31/2025390,400 shares $5.87 million -0.3%2.9%5.3 $15.03 3/15/2025391,600 shares $6.23 million +5.0%2.9%5.2 $15.91 2/28/2025372,800 shares $6.51 million -2.0%2.6%5.2 $17.45 2/15/2025380,300 shares $6.79 million -1.3%2.7%5.1 $17.86 1/31/2025385,100 shares $6.57 million -4.3%2.7%4.4 $17.06 1/15/2025402,300 shares $6.44 million +3.1%2.9%4 $16.02 12/31/2024390,200 shares $6.42 million +2.6%2.8%4 $16.46 12/15/2024380,400 shares $6.53 million +3.5%2.7%4 $17.16 11/30/2024367,500 shares $6.51 million -27.8%2.6%4 $17.72 11/15/2024508,900 shares $8.78 million +5.1%3.6%6 $17.25 10/31/2024484,400 shares $8.29 million -1.0%3.4%6.8 $17.11 10/15/2024489,100 shares $12.30 million -23.5%3.4%9.9 $25.15 9/30/2024639,300 shares $15.79 million -5.1%4.5%12.7 $24.70 9/15/2024673,300 shares $16.59 million -0.5%4.7%13.1 $24.64 8/31/2024676,700 shares $17.39 million +0.2%4.7%14.5 $25.70 8/15/2024675,300 shares $17.25 million +0.9%4.7%13.8 $25.54 7/31/2024669,200 shares $18.24 million -6.0%4.7%12.9 $27.25 7/15/2024712,200 shares $19.62 million -2.9%5.0%13.4 $27.55 6/30/2024733,200 shares $18.57 million 0.0%N/A13.7 $25.33 6/15/2024733,400 shares $19.27 million -1.5%N/A12.9 $26.28 5/31/2024744,500 shares $19.10 million -5.6%N/A11.1 $25.65 5/15/2024788,500 shares $20.56 million -2.4%N/A10.2 $26.08 4/30/2024808,100 shares $20.92 million -0.4%5.6%10.1 $25.89 4/15/2024811,100 shares $20.53 million +5.3%5.7%9.9 $25.31 3/31/2024770,400 shares $19.57 million +0.6%5.4%9 $25.40 3/15/2024766,100 shares $19.49 million +32.4%5.4%9.1 $25.44 2/29/2024578,500 shares $14.05 million +1.1%4.1%7.5 $24.28 2/15/2024572,300 shares $14.07 million +8.4%4.0%6.9 $24.59 1/31/2024527,800 shares $12.41 million +1.2%3.7%6.5 $23.52 1/15/2024521,700 shares $11.68 million -3.2%3.7%6 $22.38 12/31/2023538,900 shares $12.21 million +6.9%3.8%5.7 $22.66 12/15/2023504,200 shares $11.25 million -3.6%3.5%4.9 $22.32 11/30/2023523,000 shares $11.46 million +6.9%3.7%2.9 $21.91 11/15/2023489,100 shares $10.02 million -7.5%3.4%2.4 $20.49 10/31/2023528,900 shares $10.31 million +13.0%3.7%2.5 $19.50 10/15/2023468,200 shares $8.75 million +7.2%3.3%2.2 $18.68 9/30/2023436,700 shares $8.14 million -55.0%3.4%2.2 $18.63 9/15/2023971,300 shares $16.97 million +21.5%6.8%4.8 $17.47 8/31/2023799,200 shares $14.27 million +33.9%5.6%6.1 $17.85 8/15/2023596,700 shares $11.04 million +21.8%4.2%6.3 $18.50 7/31/2023489,800 shares $11.43 million +13.6%3.4%5.8 $23.33 7/15/2023431,100 shares $10.75 million +13.9%3.0%5.5 $24.94 6/30/2023378,500 shares $9.83 million -17.7%2.6%4.7 $25.98 6/15/2023459,700 shares $12.32 million +0.1%3.2%6.2 $26.81 5/31/2023459,100 shares $12.44 million +2.3%N/A6.3 $27.09 5/15/2023449,000 shares $11.54 million +3.8%N/A5.4 $25.70 4/30/2023432,500 shares $11.10 million -6.1%3.0%5.3 $25.66 4/15/2023460,500 shares $12.77 million -0.5%3.2%5.7 $27.72 3/31/2023463,000 shares $13.30 million -0.7%3.2%5.8 $28.72 3/15/2023466,200 shares $12.55 million -11.8%3.3%5.3 $26.92 2/28/2023528,800 shares $16.76 million +3.2%3.7%5.7 $31.70 2/15/2023512,300 shares $15.82 million +1.6%3.6%5.8 $30.88 1/31/2023504,100 shares $15.63 million -7.1%3.5%5.3 $31.01 1/15/2023542,800 shares $16.83 million -17.3%3.8%5.4 $31.00 12/30/2022656,200 shares $19.42 million +12.1%4.6%6.3 $29.60 12/15/2022585,600 shares $17.17 million -30.9%4.1%5.5 $29.32 11/30/2022847,400 shares $26.73 million -11.5%5.9%9 $31.54 11/15/2022957,100 shares $29.91 million -3.0%6.7%10.3 $31.25 10/31/2022987,100 shares $28.05 million -0.8%6.9%11.3 $28.42 10/15/2022994,800 shares $23.73 million +0.5%7.0%12.3 $23.85 9/30/2022989,600 shares $23.55 million +7.9%6.9%12.3 $23.80 9/15/2022917,300 shares $20.94 million -4.7%6.4%11 $22.83 8/31/2022962,000 shares $21.74 million -3.5%6.7%10.2 $22.60 8/15/2022996,600 shares $22.64 million -3.2%7.0%10.2 $22.72 7/31/20221,030,000 shares $24.06 million -1.9%7.6%9.5 $23.36 7/15/20221,050,000 shares $24.34 million No Change7.7%9.5 $23.18 6/30/20221,050,000 shares $23.44 million -7.9%7.7%9.5 $22.32 6/15/20221,140,000 shares $25.03 million +7.6%8.4%10.7 $21.96 5/31/20221,060,000 shares $23.04 million No Change7.4%11.1 $21.74 5/15/20221,060,000 shares $23.62 million -2.8%7.4%11.9 $22.28 4/30/20221,090,000 shares $23.47 million No Change7.7%12.5 $21.53 4/15/20221,090,000 shares $25.28 million -3.5%7.7%13.9 $23.19 3/31/20221,130,000 shares $28.37 million -4.2%7.9%13.4 $25.11 3/15/20221,180,000 shares $29.92 million +5.4%8.3%13 $25.36 2/28/20221,120,000 shares $36.40 million -1.8%7.9%12.1 $32.50 2/15/20221,140,000 shares $35.10 million +2.7%8.0%12.4 $30.79 1/31/20221,110,000 shares $35.30 million -0.9%7.8%11.7 $31.80 1/15/20221,120,000 shares $38.32 million +14.5%7.9%12.6 $34.21 12/31/2021978,200 shares $35.05 million +13.1%6.9%11.7 $35.83 12/15/2021864,600 shares $34.20 million +7.0%6.1%11.3 $39.56 11/30/2021807,800 shares $31.61 million +6.8%5.7%11.2 $39.13 11/15/2021756,300 shares $29.50 million -29.3%5.3%10.5 $39.01 10/29/20211,070,000 shares $44.57 million No Change7.5%15.5 $41.65 10/15/20211,070,000 shares $44.58 million +0.9%7.5%16 $41.66 9/30/20211,060,000 shares $45.11 million -12.4%7.4%15.4 $42.56 9/15/20211,210,000 shares $48.16 million +0.8%8.5%17 $39.80 8/31/20211,200,000 shares $51.76 million -4.8%8.4%15.3 $43.13 8/13/20211,260,000 shares $52.72 million -3.1%8.8%14.7 $41.84 7/30/20211,300,000 shares $52.17 million -0.8%9.1%14.7 $40.13 7/15/20211,310,000 shares $53.42 million -3.0%9.2%13.7 $40.78 6/30/20211,350,000 shares $58.44 million -8.8%9.5%13 $43.29 6/15/20211,480,000 shares $63.26 million -7.5%10.4%10.8 $42.74 5/28/20211,600,000 shares $74.64 million -1.2%11.2%12 $46.65 5/14/20211,620,000 shares $69.14 million -1.8%N/A11.5 $42.68 4/30/20211,650,000 shares $66.92 million -2.4%N/A11.1 $40.56 4/15/20211,690,000 shares $69.22 million +17.4%N/A11.3 $40.96 3/31/20211,440,000 shares $54.76 million +7.5%N/A9.7 $38.03 3/15/20211,340,000 shares $49.67 million +3.1%N/A10.8 $37.07 2/26/20211,300,000 shares $48.61 million -7.1%N/A10.6 $37.39 2/12/20211,400,000 shares $52.63 million -4.1%N/A12.3 $37.59 1/29/20211,460,000 shares $55.13 million -2.0%N/A13.7 $37.76 1/15/20211,490,000 shares $61.09 million -8.6%N/A14.1 $41.00 12/31/20201,630,000 shares $73.01 million -3.6%N/A15.9 $44.79 12/15/20201,690,000 shares $64.98 million -2.3%N/A16.3 $38.45 11/30/20201,730,000 shares $66.21 million -2.8%N/A16.5 $38.27 11/15/20201,780,000 shares $67.30 million -1.7%N/A16.6 $37.81 10/30/20201,810,000 shares $60.71 million +3.4%N/A16.7 $33.54 10/15/20201,750,000 shares $65.71 million -3.3%N/A15.6 $37.55 ANIK Short Interest - Frequently Asked Questions What is Anika Therapeutics' current short interest? Short interest is the volume of Anika Therapeutics shares that have been sold short but have not yet been covered or closed out. As of September 15th, investors have sold 360,100 shares of ANIK short. 2.62% of Anika Therapeutics' shares are currently sold short. Learn More on Anika Therapeutics' current short interest. What is a good short interest ratio for Anika Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ANIK shares currently have a short interest ratio of 3.0. Learn More on Anika Therapeutics's short interest ratio. Which institutional investors are shorting Anika Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Anika Therapeutics: Group One Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Anika Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.62% of Anika Therapeutics' floating shares are currently sold short. Is Anika Therapeutics' short interest increasing or decreasing? Anika Therapeutics saw a decrease in short interest in September. As of September 15th, there was short interest totaling 360,100 shares, a decrease of 10.9% from the previous total of 404,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Anika Therapeutics' float size? Anika Therapeutics currently has issued a total of 14,420,000 shares. Some of Anika Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Anika Therapeutics currently has a public float of 13,720,000 shares. How does Anika Therapeutics' short interest compare to its competitors? 2.62% of Anika Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Anika Therapeutics: Annovis Bio, Inc. (8.16%), Cerus Corporation (5.75%), OraSure Technologies, Inc. (5.59%), Utah Medical Products, Inc. (3.83%), West Pharmaceutical Services, Inc. (2.35%), The Cooper Companies, Inc. (3.14%), Align Technology, Inc. (3.29%), Merit Medical Systems, Inc. (5.44%), ICU Medical, Inc. (6.07%), DENTSPLY SIRONA Inc. (4.47%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks. What does it mean to sell short Anika Therapeutics stock? Short selling ANIK is an investing strategy that aims to generate trading profit from Anika Therapeutics as its price is falling. ANIK shares are trading up $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Anika Therapeutics? A short squeeze for Anika Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ANIK, which in turn drives the price of the stock up even further. How often is Anika Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ANIK, twice per month. The most recent reporting period available is September, 15 2025. More Short Interest Resources from MarketBeat Related Companies ANVS Short Interest Data CERS Short Interest Data OSUR Short Interest Data UTMD Short Interest Data WST Short Interest Data COO Short Interest Data ALGN Short Interest Data MMSI Short Interest Data ICUI Short Interest Data XRAY Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ANIK) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredTrump’s new AI budget just passed — one stock could soarIn a quiet move few people noticed... President Trump just green-lit what could become the biggest AI budge...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anika Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anika Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
